Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Simone Boehrer, MD
Woman and Man Max 99 years
Simone Boehrer, MD
Update Il y a 4 ans
Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)
A phase I/II study of the efficacy and safety of an intensified schedule of Azacitidine (Vidaza®) in intermediate-2 and high risk MDS patients.
Country
France
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Simone Boehrer, MD
Update Il y a 4 ans
Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)
The study is aimed to treat low-risk MDS patients,who are dependent on red-blood cell transfusion due to disease-related anemia, and who have a proven resistance towards treatment with ery...
Country
None
organs
None
Specialty
None
Closed trial
More information